Athos Therapeutics Funding & Investors
Torrance, CA
Athos Therapeutics is a late pre-clinical stage biotechnology company pioneering the development of artificial intelligence-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.
athostx.comTotal Amount Raised: $54,250,000
Athos Therapeutics Funding Rounds
Series B
$35,000,000
Series A
$15,000,000
Seed
$4,250,000
Funding info provided by Diffbot.